Displaying 101 - 120 of 5080
Edwards Lifesciences Corp. and JenaValve Technology, Inc., In the Matter of
The Federal Trade Commission issued an administrative complaint to block medical device supplier Edwards Lifesciences Corp.’s (Edwards) proposed acquisition of JenaValve Technology, Inc. (JenaValve) due to concerns that the acquisition would limit patient access to lifesaving medical devices used to treat a potentially fatal heart condition. On January 9, 2026, after a six-day trial, the U.S. District Court for the District of Columbia granted the FTC’s request for a preliminary injunction to temporarily prevent Edwards from acquiring JenaValve.
Remarks of Chairman Andrew N. Ferguson at FTC Workshop on Noncompete Agreements
FTC Hosts Workshop on Noncompete Agreements
Epic Games Inc. v. Google LLC et al.
FTC Appeals Ruling in Meta Monopolization Case
FTC Announces 2026 Jurisdictional Threshold Updates for Interlocking Directorates
FTC Announces 2026 Update of Jurisdictional and Fee Thresholds for Premerger Notification Filings
Edwards Lifesciences Corporation and JenaValve Technology, Inc., FTC v.
Statement on FTC Victory Halting Anticompetitive Medical Device Deal
FTC Issues Annual Report on Ethanol Market Concentration 2025
Adamas Amenity Services LLC, et al.; Analysis of Agreement Containing Consent Order To Aid Public Comment
Displaying 101 - 120 of 5080